Drugs / DA-5218
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05449704 | Jul → Sep 2022 | — | Dong-A ST Co., Ltd. | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07229534 | Nov 2025 → Nov 2027 expected | type 2 diabetes mellitus | Dong-A ST Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5218 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05449704 ↗ |